Deregulation of C-MYC has been implicated with aggressive lymphomas and adverse prognosis in B-cell malignancies as it plays a role by promoting cell cyle progression and tumour proliferation in DLBCL. Here, MYC is linked to diffuse large B-cell lymphoma.